Loperamide, an FDA-Approved Antidiarrhea Drug, Effectively Reverses the Resistance of Multidrug Resistant MCF-7/MDR1 Human Breast Cancer Cells to Doxorubicin-Induced Cytotoxicity

By Zhou Yanfei   Sridhar Rajagopalan   Shan Liang   Sha Wei   Gu Xinbin   Sukumar Saraswati  

Cancer Investigation, Vol. 30, Iss. 2, 2012-02 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5

By Yang Ge   Jiang Ou   Ling Daiqiong   Jiang Xiaoyue   Yuan Pingzong   Zeng Guang   Zhu Jing   Tian Jie   Weng Yaguang   Wu Daoquan  

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-09 ,pp. : 3930-3936

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines

By          

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 7335-7343

Spandidos Publications

Access to resources Recommend Favorite

Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure

By Guo Baoqing  

Breast Cancer Research and Treatment, Vol. 85, Iss. 1, 2004-05 ,pp. : 31-51

Springer Publishing Company

Access to resources Recommend Favorite

Cross-resistance to cisplatin in cells with acquired resistance to copper

By Safaei Roohangiz   Katano Kuniyuki   Samimi Goli   Naerdemann Wiltrud   Stevenson Jennifer   Rochdi Myriam   Howell Stephen  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 239-246

Springer Publishing Company

Access to resources Recommend Favorite